Fig. 1. Algorithm for clinical approach for incidental pancreatic cystic lesions. SCA=Serous cystadenoma; MCT=Mucinous cystic tumor; IPMN=Intraductal papillary mucinous neoplasm; ERCP=Endoscopic retrograde cholangiopancreatography; EUS=Endoscopic ultrasonography; FNA=Fine needle aspiration; MPD=Main pancreatic duct; USG=Ultrasonography; CT=Computed Tomography. Cystic lesions of the pancreas are being incidentally recognized with increasing frequency and become a common finding in clinical practice. Most pancreatic cystic neoplasms are detected incidentally when abdominal imaging is performed for other indications [1]. Incidental pancreatic cystic lesions can either be neoplastic (eg, intraductal papillary mucinous neoplasms) or non-neoplastic. There are four subtypes of pancreatic cystic neoplasms which have varying malignant potential using the WHO histological classification [2,3] : -Serous cystic tumors -Mucinous cystic neoplasms -Intraductal papillary mucinous neoplasms -Solid pseudopapillary neoplasms
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Cystic lesions of the pancreas are being incidentally recognized with increasing frequency and become a common finding in clinical practice. Most pancreatic cystic neoplasms are detected incidentally when abdominal imaging is performed for other indications [1] . Incidental pancreatic cystic lesions can either be neoplastic (eg, intraductal papillary mucinous neoplasms) or non-neoplastic. There are four subtypes of pancreatic cystic neoplasms which have varying malignant potential using the WHO histological classification [2, 3] :
-Serous cystic tumors -Mucinous cystic neoplasms -Intraductal papillary mucinous neoplasms -Solid pseudopapillary neoplasms Despite of recent remarkable advances of radiological and endoscopic assessment and a better understanding of natural history of certain subgroups of cystic lesions, differentiation among lesions and making an optimal management plan is still challenging. A multimodal approach should be performed to evaluate Incidental pancreatic cystic lesions. Emerging evidence supports selective nonoperative management for the majority of patients with cystic lesions, but, for those in whom a suspicion of malignancy remains, surgery is indicated [4] . Concerning long-term follow-up, he majority of pancreatic cystic lesions have an indolent behavior and a favorable prognosis. However, long-term surveillance for more than five years should be performed because of the potential for growth and malignant transformation of pancreatic cystic lesions [5] . Based on current evidence an algorithm ( Fig. 1) for the management of a patient presenting with pancreatic cystic lesions might be proposed. However, Evidence-based guidelines for the diagnosis, management, and follow-up of cystic lesions of the pancreas should be established through the further study.
